Cargando…

Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy

BACKGROUND: Immune checkpoint therapies (ICTs) targeting the programmed cell death-1 (PD1)/programmed cell death ligand-1 (PD-L1) pathway have improved outcomes for patients with non-small cell lung cancer (NSCLC), particularly those with high PD-L1 expression. However, the predictive value of manua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Althammer, Sonja, Tan, Tze Heng, Spitzmüller, Andreas, Rognoni, Lorenz, Wiestler, Tobias, Herz, Thomas, Widmaier, Moritz, Rebelatto, Marlon C., Kaplon, Helene, Damotte, Diane, Alifano, Marco, Hammond, Scott A., Dieu-Nosjean, Marie-Caroline, Ranade, Koustubh, Schmidt, Guenter, Higgs, Brandon W., Steele, Keith E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501300/ https://www.ncbi.nlm.nih.gov/pubmed/31060602 http://dx.doi.org/10.1186/s40425-019-0589-x

Ejemplares similares

Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC
por: Devi-Marulkar, Priyanka, et al.
Publicado: (2022)

Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis
por: Widmaier, Moritz, et al.
Publicado: (2019)

Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
por: Steele, Keith E., et al.
Publicado: (2018)

Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients
por: Germain, Claire, et al.
Publicado: (2021)

Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
por: Kapil, Ansh, et al.
Publicado: (2018)

Prognostic value of LIPC in non-small cell lung carcinoma
por: Alifano, Marco, et al.
Publicado: (2013)

A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality
por: Zhu, Wei, et al.
Publicado: (2015)

Loss of Kindlin-1 Causes Skin Atrophy and Lethal Neonatal Intestinal Epithelial Dysfunction
por: Ussar, Siegfried, et al.
Publicado: (2008)

New Therapeutic Strategies for Lung Cancer
por: Icard, Philippe, et al.
Publicado: (2021)

Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer
por: Alifano, Marco, et al.
Publicado: (2014)

Tumor response from durvalumab (MEDI4736) + tremelimumab treatment in patients with advanced non-small cell lung cancer (NSCLC) is observed regardless of PD-L1 status
por: Rizvi, Naiyer, et al.
Publicado: (2015)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
por: Sautès-Fridman, Catherine, et al.
Publicado: (2016)

Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?
por: Teillaud, Jean-Luc, et al.
Publicado: (2017)

Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
por: Germain, Claire, et al.
Publicado: (2015)

microRNA-mediated regulation of innate immune response in rheumatic diseases
por: Luo, Xiaobing, et al.
Publicado: (2013)

Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin
por: Theodosiou, Marina, et al.
Publicado: (2016)

Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
por: Lawand, Myriam, et al.
Publicado: (2017)

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
por: Garaud, Soizic, et al.
Publicado: (2022)

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
por: Russick, Jules, et al.
Publicado: (2020)

Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis
por: Guo, Xiang, et al.
Publicado: (2014)

Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years’ Experience at a High-Volume Referral Center
por: Iaffaldano, Amedeo, et al.
Publicado: (2021)

Twenty-Year Survival of Patients Operated on for Non-Small-Cell Lung Cancer: The Impact of Tumor Stage and Patient-Related Parameters
por: Schussler, Olivier, et al.
Publicado: (2022)

Genomic signatures characterize leukocyte infiltration in myositis muscles
por: Zhu, Wei, et al.
Publicado: (2012)

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
por: Jiang, Liyan, et al.
Publicado: (2014)

Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous epithelial stem cell proliferation
por: Rognoni, Emanuel, et al.
Publicado: (2014)

Predictive Models of Gene Regulation from High-Throughput Epigenomics Data
por: Althammer, Sonja, et al.
Publicado: (2012)

Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy
por: Peranzoni, Elisa, et al.
Publicado: (2017)

Characteristics of tertiary lymphoid structures in primary cancers
por: Goc, Jérémy, et al.
Publicado: (2013)

Identification of host interactions for phenotypic antimalarial hits
por: Spitzmüller, Andreas, et al.
Publicado: (2014)

Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
por: Spitzmüller, Andreas, et al.
Publicado: (2013)

Metabolic features of cancer cells impact immunosurveillance
por: Joseph, Adrien, et al.
Publicado: (2021)

1st French-Israeli International Conference on B Cells and therapeutic antibodies: October 23–25, 2011 Jerusalem, Israel
por: Reynaud, Claude-Agnès, et al.
Publicado: (2012)

Structural constraints revealed in consistent nucleosome positions in the genome of S. cerevisiae
por: Nikolaou, Christoforos, et al.
Publicado: (2010)

Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
por: Ranade, Anantbhushan, et al.
Publicado: (2019)

Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?
por: Bellesoeur, Audrey, et al.
Publicado: (2019)

Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration
por: Bougherara, Houcine, et al.
Publicado: (2015)

Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study
por: Boudou-Rouquette, Pascaline, et al.
Publicado: (2021)

Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage
por: Icard, Philippe, et al.
Publicado: (2020)

Pyicos: a versatile toolkit for the analysis of high-throughput sequencing data
por: Althammer, Sonja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tsoesdmkur4e0qipogkqlkcf6o